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Abstract
Hepatocytes from cirrhotic murine livers exhibit increased basal ROS activity and resistance to
TGFβ-induced apoptosis, yet when ROS levels are decreased by antioxidant pretreatment, these cells
recover susceptibility to apoptotic stimuli. To further study these redox events, hepatocytes from
cirrhotic murine livers were pretreated with various antioxidants prior to TGFβ treatment and the
ROS activity, apoptotic response, and mitochondrial ROS generation were assessed. In addition,
normal hepatocytes were treated with low-dose H2O2 and ROS and apoptotic responses determined.
Treatment of cirrhotic hepatocytes with various antioxidants decreased basal ROS and rendered them
susceptible to apoptosis. Examination of normal hepatocytes by confocal microscopy demonstrated
co-localization of ROS activity and respiring mitochondria. Basal assessment of cirrhotic hepatocytes
showed non-focal ROS activity that was abolished by antioxidants. After pretreatment with an
adenovirus expressing MnSOD, basal cirrhotic hepatocyte ROS was decreased and TGFβ-induced
co-localization of ROS and mitochondrial respiration was present. Treatment of normal hepatocytes
with H2O2 resulted in a sustained increase in ROS and resistance to TGFβ apoptosis that was reversed
when these cells were pretreated with an antioxidant. In conclusion, cirrhotic hepatocytes have a
non-focal distribution of ROS. However, normal and cirrhotic hepatocytes exhibit mitochondrial
localization of ROS that is necessary for apoptosis.
Keywords
Reactive oxygen species (ROS); hepatocytes; apoptosis; transforming growth factor beta (TGFβ);
mitochondria
List of Abbreviations
AdCat: Adenovirus expressing catalase; AdLuc: Adenovirus expressing luciferase; AdMnSOD:
Adenovirus expressing MnSOD; DMNQ: 2,3-dimethoxy-1,4-naphthoquinone; H2-DCFDA: 2’,7’-
dichlorofluorescein diacetate; ROS: Reactive oxygen species; TGFβ: Transforming growth factor
beta 1
To whom correspondence should be addressed: Kevin E. Behrns, M. D. Professor of Surgery, Division of General Surgery, University




Free Radic Biol Med. Author manuscript; available in PMC 2007 December 1.
Published in final edited form as:














Transforming growth factor beta (TGFβ) induces apoptosis in normal murine hepatocytes
through an apoptotic pathway that requires reactive oxygen species (ROS) generation, the
mitochondrial permeability transition (MPT) with cytochrome c release, and caspase activation
[1]. The increase in ROS after TGFβ is an early event that occurs within 90 minutes, lasts
approximately three hours, and precedes the MPT and caspase activation [1,2]. Furthermore,
inhibition of a ROS burst abolishes the apoptotic response and related intracellular events [1–
3]. The source and mechanism of TGFβ-induced ROS has been attributed to the mitochondria,
microsomes, and membrane-associated NADPH oxidase-like systems, yet the evanescent
nature of ROS has made definitive source identification difficult [4,5]. In addition, TGFβ-
induced down-regulation of the anti-oxidant, glutathione, further complicates the balance of
ROS production versus scavenger activity [4,6]. Therefore, although ROS play an integral role
in hepatocyte death following TGFβ administration, the necessity of ROS and the intracellular
mechanisms through which ROS-mediated events occur remain unclear.
Despite the requirement of ROS generation for TGFβ-induced hepatocyte apoptosis in normal
cells, increased intracellular ROS in chronic inflammatory states does not inevitably induce
parenchymal cell death, and, in fact, may allow an adaptive state that protects against cell death
[1]. Previous work demonstrated that in a carbon tetrachloride (CCl4)-induced murine model
of liver cirrhosis, hepatocytes isolated from this chronically inflamed liver have a greater than
1.5-fold increase in ROS under basal conditions, fail to generate a ROS burst in response to
TGFβ, resist apoptosis, yet upon pretreatment with the anti-oxidant, trolox, recovered
responsiveness to TGFβ-induced programmed cell death [1]. The association between
increased cellular ROS and resistance to cell death has been noted not only in chronic
inflammatory conditions, but also in neoplastic cells and changes in ROS may be associated
with a malignant phenotype [7,8]. The source of ROS generation in chronic inflammation and
neoplasia is unknown in these disease states in which chronic hypoxia may instigate free radical
generation. Moreover, initiation of a single oxygen-derived free radical pathway within a given
cellular locale can propagate rapidly and exponentially to multiple intertwined oxidant
generating pathways within various cellular compartments thereby rendering identification of
the primary ROS generating pathway difficult.
The cellular ROS state represents the balance of free radical production and maintenance versus
anti-oxidant scavenging activity, and, therefore, the cellular expression of anti-oxidant
enzymes such as the catalase, superoxide dismutases (SOD) 1 and 2, and the glutathione
peroxidase systems should be examined in chronic inflammation and neoplasia. Previous
studies have documented decreased anti-oxidant gene expression both in non-inflammatory
and in inflammatory and neoplastic conditions [4]. Furthermore, other studies have suggested
that anti-oxidants such as SOD2 (MnSOD) may act as tumor suppressors by controlling the
cellular ROS state [8]. Because the expression of anti-oxidant enzymes at the time of ROS
generation is often unknown, it is difficult to discern if decreased anti-oxidant expression is
the cause of or results from increased ROS [4]. Furthermore, the variability in quantifying ROS
at a given time and the relative specificity of various exogenous anti-oxidants for oxidative
pathways leads one to question the importance of decreased anti-oxidants as a primary cause
for the increased ROS in disease state like inflammation and neoplasia.
Because our previous data [1] suggested that an increase in ROS resulted in TGFβ-induced
apoptosis in normal hepatocytes but prevented apoptosis in hepatocytes from a cirrhotic liver,
we sought to examine these hepatocytes from normal and cirrhotic livers to further elucidate
the importance of ROS in hepatocyte responsiveness to pro-apoptotic stimuli such as TGFβ.
We found that in normal hepatocytes, TGFβ-induced ROS was initiated in the mitochondria
and that inhibition of ROS precluded apoptosis. In addition, under basal conditions, cirrhotic
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hepatocytes demonstrated a diffuse increase in ROS which was abolished with trolox and in
response to TGFβ these anti-oxidant treated cells demonstrated an acute increase in
mitochondrial derived ROS. Finally, normal hepatocytes treated with low-dose H2O2




Adult, eight week-old, male BALB/c mice were obtained from Harlan Laboratories
(Indianapolis, IN). Deferoxamine, 2,3-dimethoxy-1,4-naphthoquinone (DMNQ), glutathione,
N, N-Diphenyl-1,4-phenylenediamine (DPPD), N-acetylcysteine (NAC), and trolox were
acquired from Sigma Chemical (St. Louis, MO). Catalase adenovirus (AdCat) was a kind gift
from the University of Iowa Vector Core. SOD2 (AdMnSOD) and luciferase (AdLuc)
adenoviruses were obtained from the UNC Chapel Hill Vector Core. Anti-caspase 3 rabbit
polyclonal antibody was purchased from Cell Signaling Technology (Beverly, MA). 2’, 7’-
dichlorofluorescein diacetate (H2-DCFDA) and MitoTracker Red (MTR) were obtained from
Molecular Probes (Eugene, OR).
Hepatocyte Isolation and Culture
Eight week-old, male BALB/c mice weighing 20–25 grams were injected in the peritoneum
twice-weekly with 2 ml/kg of 50% carbon tetrachloride (CCl4; cirrhotic mice) in sterile mineral
oil or an equal volume of mineral oil alone for a total of eight weeks [1]. All hepatocyte
isolations were performed following a 7-day recovery. Hepatocytes were isolated through an
abdominal incision that allowed cannulation of the inferior vena cava, clamping of the
suprahepatic inferior vena cava, and transection of the portal vein. The liver was perfused in
retrograde fashion through the hepatic veins. Initially, the liver was perfused with a solution
containing 0.25 M HEPES, 115 mM NaCl, 50mM KCl, 10mM KH2PO4, and 0.5 mM EGTA
at pH 7.4 for a total volume of 50–100 ml. The perfusate was changed to a solution without
EGTA but containing 1mM CaCl2 and 0.4 mg/ml type I collagenase (0.6 mg/ml for cirrhotic
livers, Worthington Biochemical. Lakewood, NJ) at pH 7.4 for a total volume of 100–150 ml.
The liver was excised, combed manually to disperse the cells, and subjected to differential
centrifugation. Cell viability was determined using Trypan blue exclusion with a viability of
>90% accepted for experiments. Hepatocytes were plated in Waymouth’s medium
supplemented with 10% fetal calf serum, 5 μg/ml insulin, and 100 nmol/L dexamethasone.
After two hours, the medium was changed to hormonally defined medium (HDM) containing
insulin (5 μg/ml, Sigma Biochemical, St. Louis, MO), transferrin (5 μg/ml), selenium (30 nM),
and free fatty acid (1.52 μM of palmitic acid, palmitoleic acid, stearic acid, oleic acid, linoleic
acid and linolenic acid, Sigma Biochemical, St. Louis, MO).
Adenovirus Purification and Infection
The replication-deficient adenoviruses expressing either the luciferase (AdLuc), as a control,
catalase (AdCat), or manganese superoxide dismutase (AdMnSOD) were prepared and stored
as described previously [1]. Twenty-four hours prior to treatment control and cirrhotic
hepatocytes were infected at a multiplicity of infection of 100. Expression of the transgene was
confirmed by immunoblot or luciferase assay and transfection efficiency was routinely greater
than 80%.
Morphologic Assessment of Apoptosis
Propidium iodide (PI) staining and fluorescent microscopy was used for morphologic
assessment of apoptosis [1]. Hepatocytes were fixed with methanol-acetic acid (3:1) for 10
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minutes at 4°C, washed twice, and stained with PI (0.33 mg/ml) and visualized under green
excitation light using a IX-Olympus microscope (Olympus, Tokyo, Japan). The number of
condensed nuclei in five high-powered fields (X400) was determined as a percent of the total
number of nuclei.
ROS Determination
Cells were assayed in triplicate at a density of 1x105 per well in a 12-well plate and after
removing media one ml H2-DCFDA solution (10 μM in DMSO) was added and incubated at
37°C for 20 minutes. H2O2-treated cells served as positive controls. Fluorescence was
determined in a Fluostar Spectrofluorometer (BMG Labtech, Durham, NC) and read with
wavelengths of excitation of 488 nm and emission of 525 nm, respectively. Cell lysates were
the harvested for determination of protein concentration using the Bradford assay.
Immunoblot Analysis
To obtain whole cell extracts, cells were rinsed twice in PBS and lysed in buffer containing
0.05 M Tris, pH 7.3, 0.15 M NaCl, 1% NP40, 0.5% deoxycholate, and the protease inhibitor
cocktail (Sigma) for 10 minutes at 4°C. Samples were centrifuged at 14,000 rpm to remove
debris and the protein concentration was determined by Bradford assay. Following SDS-
polyacrylamide gel electrophoresis, samples were transferred to PVDF membranes and
blocked in 5% non-fat milk in TBS-T. After a one hour incubation with primary antibodies at
concentrations recommended by the manufacturers, blots were washed for 15 minutes in TBS-
T, incubated with HRP-conjugated secondary antibody (1:1000) for 30 minutes, washed for
15 minutes in TBS-T and visualized by enhanced chemiluminescence (Amersham Biosciences,
Piscataway, NJ) and exposed to a Biomax-MS film (PerkinElmer, Boston, MA).
Caspase Activity
Caspase-3 activity was assessed by a colorimetric enzyme assay (BD Biosciences, San Jose,
CA) [1]. Each assay was performed in triplicate with 2x106 hepatocytes. Cell lysates from
treated or untreated hepatocytes were incubated with 50 μl of 2X reaction buffer/DTT and 5
μl of 1 mM caspase-3 substrate (DEVD-pNA) was added. Following incubation at 37°C for
one hour absorbance was determined at 405 nm in a spectrophotometer.
Confocal Microscopy
Localization of TGFβ-induced ROS production to mitochondria was investigated in
hepatocytes dual-labeled with H2-DCFDA (green fluorescence) to detect ROS and
MitoTracker Red (MTR; Molecular Probes, Eugene, OR) to detect mitochondria [1]. MTR is
electrophoretically taken up by the mitochondria. After uptake, MTR becomes covalently
bound to sulfhydryl groups of mitochondrial proteins and remains in the mitochondria even if
the mitochondrial depolarize [9,10]. Co-localization of these signals yields a yellow signal that
indicates mitochondria actively producing ROS. Hepatocytes, 3 X 105, were plated overnight
in a MatTek culture dish (MatTek, Ashland, MA) and treated or untreated for 20 minutes at
37°C and H2-DCFDA and MTR were added to achieve final concentrations of 2 μM and 500
nM, respectively. After one hour incubation, the medium were aspirated, hepatocytes were
subjected to two wash steps with PBS, and confocal imaging performed. Confocal images were
obtained with a Zeiss LSM 510 laser scanning confocal microscope (Thornwood, NY).
Detector gain was equal in both experimental and control groups. Cells were randomly selected
and analyzed for co-localization of H2-DCF fluorescence and mitochondrial staining with
MTR. The images of green H2-DCF and red MTR were superimposed and distinct regions of
yellow provided direct evidence of mitochondrial derived ROS. The detector gains used on the
confocal microscope for both the dyes were selected so as to not obscure visualization of
subcellular features of the cell while still allowing discrimination of signals proportional to
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activity. These gain levels were not altered during the course of the experiments. However, by
keeping gains constant, MTR intensity levels varied slightly between the experiments. Images
were background corrected before analysis and average fluorescence was calculated using
Adobe Photoshop (San Jose, CA).
H2O2-Treated Hepatocytes
Normal hepatocytes were treated with 10 μM H2O2 for 10–20 minutes and ROS activity
assessed with H2-DCF for 72 hours. ROS activity in these hepatocytes was increased
approximately two-fold and maintained this level of activity for 72 hours. This ROS activity
is similar to that seen in cirrhotic hepatocytes at baseline. These cells were then subjected to
TGFβ treatment and apoptosis determined at 48 hours as described previously.
Determination of Protein Tyrosine Phosphatase Activity
Protein tyrosine phosphatase activity was spectrometrically determined using p-nitrophenyl
phosphate [11].
Data Analysis
All experiments were performed in at least triplicate. Data are reported as mean plus or minus
the standard deviation. Statistical analysis was performed using ANOVA and Dunnett’s t-test
and a p-value of 0.05 was considered significant.
RESULTS
Exogenous Antioxidants and Cirrhotic Hepatocyte Apoptosis
Previous work from our laboratory demonstrated that cirrhotic hepatocyte resistance to
TGFβ-induced apoptosis was mediated through ROS and that pretreatment with trolox
decreased ROS and rendered these hepatocytes susceptible to TGFβ-induced apoptosis [1]. To
determine if antioxidants selective for specific ROS generating pathways would provide
information about the source of ROS production in cirrhotic hepatocytes, these cells were
treated with 1.5 mM deferoxamine, 5 mM glutathione, 5 μM DPPD, or 2.5 mM NAC for 1
hour. Each treatment group exhibited a significant decrease that returned ROS to control levels
in response to the various antioxidants (data not shown). Furthermore, following antioxidant
pretreatment each group demonstrated a significant increase in ROS generation after TGFβ
administration (Fig. 1A). This ROS spike 90 minutes after TGFβ administration corresponds
to generation of a ROS burst that occurs in normal hepatocytes [1]. Importantly, the ROS burst
following TGFβ administration in cirrhotic hepatocytes pretreated with the various
antioxidants was associated with a significant increase in morphologic apoptosis at 48 hours
(Fig. 1B). These data suggest that cirrhotic hepatocytes respond to several exogenous
antioxidants with decreased ROS and that a reduction in baseline ROS in cirrhotic hepatocytes
permits a TGFβ-induced ROS burst with subsequent apoptosis. However, exogenous
administration of multiple antioxidants does not specify the ROS initiating pathway in cirrhotic
hepatocytes.
Adenovirus Expression of Antioxidants and Cirrhotic Hepatocyte Apoptosis
To determine if adenoviruses expressing antioxidant enzymes had an effect on cirrhotic
hepatocytes similar to exogenously applied antioxidants, adenoviruses expressing luciferase
as a control (AdLuc), catalase (AdCat), or MnSOD (AdMnSOD) were administered. The
adenoviruses expressing MnSOD and catalase both decreased ROS in cirrhotic hepatocytes
(Fig. 2A), and these cells were capable of attaining a ROS spike 90 minutes following TGFβ
treatment (Fig. 2B). The adenovirus expressing MnSOD was particularly effective in
decreasing ROS and permitting a robust ROS response to TGFβ. In addition, assessment of
Raval et al. Page 5













apoptosis (Fig. 2C) demonstrated that cirrhotic hepatocytes transduced with either the MnSOD
or catalase adenoviruses underwent significant apoptosis 48 hours following treatment with
TGFβ. These findings indicate that cirrhotic hepatocytes infected with antioxidant enzymes
behave similarly to cirrhotic hepatocytes treated with exogenous antioxidants; however,
adenoviral expression of MnSOD appeared particularly effective in reducing ROS and
permitting a TGFβ-induced ROS burst.
To confirm that caspase-mediated apoptosis was the mode of cell death in cirrhotic hepatocytes,
cell lysates from control and adenoviral infected cells were subjected to immunoblots for
activated caspase-3. The primary antibody has affinity for the inactive, pre-cleaved, 35 kDa
caspase-3 zymogen and the cleaved, activated, 17 kDa fragment. In Fig. 3A, cirrhotic
hepatocytes transduced with the luciferase alone (AdLuc; lane 1) or luciferase followed by
TGFβ (lane 2) did not exhibit the cleaved caspase-3 product. Likewise, infection with
AdMnSOD alone (lane 3) failed to result in caspase-3 cleavage. However, when cells infected
AdMnSOD for 24 hours were subsequently treated with TGFβ, caspase-3 cleavage occurred
at 48 hours following TGFβ treatment (lane 4). Similar findings were evident for cirrhotic
hepatocytes treated with AdCat (Fig. 3B). These immunoblot findings were substantiated by
a caspase assay that showed only cirrhotic hepatocytes transduced with antioxidant enzymes
and subsequently treated with TGFβ for 48 hours exhibited caspase-3 activation (Fig. 3C).
Additionally, cirrhotic hepatocytes transduced with AdMnSOD and AdCat for 24 hours and
pretreated for one hour with zVAD, a pan-caspase inhibitor, failed to undergo apoptosis in
response to TGFβ, further confirming an apoptotic mode of cell death (Fig. 3D). Collectively,
these data suggest that TGFβ-mediated cell death in cirrhotic hepatocytes pretreated with
adenoviruses expressing antioxidants is caspase-dependent.
Co-localization of TGFβ-Induced ROS and Mitochondrial Function
Because AdMnSOD administration suggested a prominent role for mitochondria in ROS
production, confocal microscopy was used to investigate TGFβ-induced ROS production in
mitochondria. In these experiments, green-fluorescent H2-DCF (2 μM) was used to identify
ROS and red fluorescent MTR (500 nM) was used to label mitochondria. The ROS response
was monitored by confocal microscopy in both normal and cirrhotic hepatocytes that were
untreated or pretreated with various antioxidants prior to administration of TGFβ. A significant
increase in baseline ROS activity was evident in untreated cirrhotic hepatocytes compared to
normal hepatocytes (Fig. 4A).
Similar to our previous study [1], normal hepatocytes treated with TGFβ underwent a ROS
burst at 90 min (Fig. 4B); however, when these normal hepatocytes were pretreated with
AdMnSOD and then administered TGFβ, a ROS burst did not occur. In normal hepatocytes,
ROS levels did not change significantly in response to antioxidant treatment alone. Similar
results were noted when AdCat and trolox were used as antioxidants.
In cirrhotic hepatocytes, AdMnSOD infection decreased significantly the basal ROS activity
(Fig. 4C). Cirrhotic hepatocytes treated with TGFβ alone did not undergo a ROS spike at 90
min, but cirrhotic cells pretreated with AdMnSOD underwent a ROS burst similar to that of
untreated control cells (Fig. 4D).
These data confirm that a reduction in ROS levels in cirrhotic hepatocytes sensitizes these
previously resistant cells to TGFβ-induced mitochondrial ROS generation and subsequent
apoptosis. Conversely, treatment of normal hepatocytes with various antioxidants renders these
formerly responsive hepatocytes resistant to TGFβ-induced mitochondrial ROS generation.
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Role of Anti-Apoptotic Proteins and Protein Tyrosine Phosphatase in Cirrhotic Livers and
Hepatocytes
To test if resistance to apoptosis in cirrhotic hepatocytes could result from modified apoptotic
machinery, lysates from normal and cirrhotic livers were immunoblotted for anti-apoptotic
proteins, including Bcl-xL and MCL-1 [12]. Levels of both Bcl-xL and MCL-1 from cirrhotic
livers were similar to those from normal livers (Fig. 5A), suggesting that upregulation of anti-
apoptotic proteins is not the mechanism underlying resistance to apoptosis in cirrhotic livers.
ROS can modify proteins, lipids and nucleic acids, leading to tissue injury. Since protein
tyrosine phosphatase is a key signaling molecule associated with TGFβ transduction and is
also known to be sensitive to oxidative stress [13,14], we examined the possibility that
enhanced basal ROS in cirrhotic hepatocytes could perturb the activity of protein tyrosine
phosphatase. Measurement of total tyrosine phosphatase activity demonstrates that there was
no significant difference in tyrosine phosphatase activity between normal and cirrhotic
hepatocytes (Fig. 5B). Moreover, treatment with TGFβ for 48 hours did not change the activity
of tyrosine phosphatase in both groups (Fig. 5B). These findings suggest that protein tyrosine
phosphatases are not significantly involved in cirrhotic hepatocyte resistance to apoptosis, and
the mechanisms other than altered tyrosine phosphatase may contribute to resistance to
apoptosis.
H2O2-Treated Normal Hepatocytes Mimic Cirrhotic Hepatocyte ROS Activity and Apoptotic
Response
Our previous work [1] and the findings in this study suggest strongly that basal ROS activity
in cirrhotic hepatocytes mediates responsiveness to TGFβ-induced apoptosis. To determine if
normal hepatocytes, which are responsive to TGFβ-induced apoptosis, could be rendered
resistant to apoptosis by increased basal ROS activity, these cells were exposed to H2O2 and
ROS activity monitored over 72 hours. Treatment with 10 μM H2O2 for produced sustained
ROS activity comparable to cirrhotic hepatocyte basal ROS activity (Fig. 6A). Additionally,
hepatocyte viability was 97% over 72 hours, indicating that this low concentration of H2O2 is
not cytotoxic (data not shown). When these H2O2-converted hepatocytes were subsequently
treated with TGFβ, an ROS burst was not apparent (data not shown). Furthermore, these
H2O2-converted hepatocytes were resistant to TGFβ-induced apoptosis (Fig. 6B). Trolox
pretreatment of normal hepatocytes resulted in the expected inhibitory response to TGFβ-
induced apoptosis compared to normal hepatocytes not treated with antioxidant. However,
trolox pretreatment of H2O2-converted hepatocytes resulted in a decrease in ROS activity and
return of the TGFβ-induced apoptotic response. To further evaluate the role of enhanced ROS
in cirrhotic hepatocytes, normal hepatocytes were treated with 30 μM 2,3-dimethoxy-1,4-
naphthoquinone (DMNQ), an intracellular redox-cycling agent [15], for 20 min. After washing
once, hepatocytes were further incubated in HDM (without DMNQ) for 24 hours in the
presence of TGFβ. Development of apoptosis was assessed by chromatin condensation and
nuclear fragmentation in PI-stained nuclei, as described in MATERIALS and METHODS (Fig.
7). DMNQ at this concentration was not cytotoxic (data not shown). In normal hepatocytes,
TGFβ treatment substantially increased apoptosis (Fig. 7A). In contrast, DMNQ-converted
hepatocytes were resistant to TGFβ-mediated apoptosis (Fig. 7B). Taken together, these
findings confirm the importance of the basal ROS activity in preventing TGFβ-induced
hepatocyte apoptosis.
DISCUSSION
ROS serve as intermediaries in cellular signaling pathways and recent studies have
demonstrated the importance of generating these molecules in apoptotic death pathways [1,4,
16]. Our previous work examining cirrhotic hepatocytes suggests that chronic elevation of
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basal ROS activity inhibits mitochondrial pathway-dependent hepatocyte apoptosis induced
by TGFβ, TNFα and UV, and the findings in this study document the crucial role for ROS in
TGFβ-induced hepatocyte apoptosis. The aim of this study was to investigate further the
necessity of ROS in hepatocyte apoptosis, and specifically to examine the importance of
mitochondrial-generated ROS activity. The major findings of this study corroborate our
previous work and extend our findings to suggest that the basal increase in cirrhotic hepatocyte
ROS likely is not limited to a single ROS generating pathway. Furthermore, we found that the
mitochondria are a primary source of TGFβ-induced ROS activity in normal hepatocytes and
in cirrhotic hepatocytes that have been pretreated with antioxidants. Finally, normal
hepatocytes exposed to H2O2 and DMNQ can be “converted” to an oxidative state that confers
resistance to TGFβ-induced apoptosis. Cumulatively, these findings suggest that ROS play an
integral role in hepatocyte responsiveness to apoptotic stimuli.
The cirrhotic liver represents the end-stage morphologic result from chronic inflammatory
injury related to viral hepatitis, alcohol ingestion, and other metabolic causes. Chronic CCl4-
induced liver injury in the mouse produces bridging fibrosis with up-regulation of fibrotic
stimuli such as TGFβ [17]. Despite increased hepatic levels of TGFβ and other pro-apoptotic
cytokines, the cirrhotic liver does not have a chronically increased rate of apoptosis [1], which
suggests that the hepatocyte exposed to chronic inflammation has adapted an anti-apoptotic
mechanism. The anti-apoptotic phenotype has been noted in several forms of liver injury
including alcohol-induced liver injury which is associated with increased ROS [18]. In that
study, hepatocellular apoptosis was decreased with a resultant increase in dysplastic
hepatocytes and these phenotypic changes were likely related to p53 expression. Furthermore,
increased ROS activity has been linked to malignant transformation [19] which may be related
to cytokine receptor profiles and resistance to apoptosis [20] or to decreased expression of
antioxidants [8,21]. In addition to decreasing responsiveness to apoptosis, increased ROS may
result in negative regulatory changes in the cell cycle and alter the balance between proliferation
and apoptosis [22]. Collectively, these findings suggest that chronically increased ROS may
mediate changes in susceptibility to apoptosis and as demonstrated by our findings and those
of Herrera et al. [4,23,24] multiple ROS generating pathways and downstream cellular
signaling pathways may be involved.
Because the mitochondria are a primary source of ROS, we [1] and others [25] have focused
on the importance of mitochondrial ROS generation in chronic hepatic inflammatory states.
The current study demonstrates that TGFβ-induced ROS activity in normal hepatocytes
predominantly arises from the mitochondria as evidenced by co-localization of H2-DCFDA
fluorescent activity and respiring mitochondria on confocal microscopic imaging. Moreover,
in cirrhotic hepatocytes that are pretreated with an antioxidant and subsequently treated with
TGFβ, significant ROS activity again arises in the mitochondria suggesting that the
mitochondria are an important source of TGFβ-induced ROS. These findings also suggest that
even though cirrhotic hepatocytes have elevated basal ROS activity, the mitochondria in these
cells are functionally intact, respond appropriately after treatment with an antioxidant, and do
not have an irreversible injury related to CCl4 administration. The mechanisms that may
influence mitochondrial ROS production have been examined closely and may be related to
the Bcl-family of proteins [26–28]. However, our results suggest that up-regulation of anti-
apoptotic proteins, Bcl-xL and MCL-1, is not the mechanism underlying resistance to apoptosis
in cirrhotic hepatocytes since levels of both proteins in cirrhotic livers were similar to those in
normal livers. In receptor-dependent apoptosis mitochondrial ROS production may be related
to a Bid-mediated induction of mitochondrial ROS [27]. Alternatively, Bax, another pro-
apoptotic Bcl-family member, may associate with the mitochondrial voltage-dependent anion
channel and modulate cytochrome c release and apoptotic cell death in the acute phase [28].
In the setting of chronic inflammation, mitochondrial function and Bcl-family function have
been less studied, but in nonalcoholic steatohepatitis (NASH) changes in the P450 system may
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up-regulate ROS production [25]. These studies suggest that several pathways may be involved
in mitochondrial ROS generation, and that further investigation is needed to determine how
these pathways may mediate ROS production in chronic inflammatory states.
Our experiments in which normal murine hepatocytes were exposed to H2O2 and exhibited
sustained ROS activity and antioxidant-reversible resistance to apoptosis suggests that the
redox state of hepatocytes mediates the TGFβ-apoptotic response. The importance of redox
state is further supported by our findings that a brief treatment of DMNQ, a redox-cycling
agent [15], to normal hepatocytes reversed the sensitivity to TGFβ-induced apoptosis. Similar
findings were noted by Tejima et al. [29] who used H2O2 as a preconditioning molecule and
demonstrated the hepatotoxicity could be reduced by low-dose H2O2. Likewise, hepatocytes
treated with nontoxic doses of menadione, a superoxide generator, resisted oxidant-induced
cell death through an ERK-dependent pathway while the JNK pathway was pro-apoptotic
[30]. Interestingly, the pro-apoptotic function of the JNK pathway appeared to be
mitochondrial-independent. Other mechanisms that may render hepatocytes resistant to
H2O2-mediated cell death involve intramitochondrial changes in caspase processing [31]. In
this study, cells treated with H2O2 demonstrated a slight decrease in the inner mitochondrial
membrane potential but without cytochrome c release. In addition, within the mitochondria,
procaspase-9 underwent autocleavage, but overexpression of the antiapoptotic protein, Bcl-2,
caused accumulation of caspase-9 and prevented oxidant-induced cell death. The
intramitochondrial processing of procaspase-9 was associated with disulfide-bonded dimers
of caspase-9 that appeared to prevent mitochondrial release. These studies suggest that
exposure to nontoxic doses of oxidants can prevent cell death by up-regulation of anti-apoptotic
cellular mechanisms.
In conclusion, these experiments demonstrate that the ROS state of hepatocytes mediates
responsiveness to TGFβ-induced apoptosis. In normal hepatocytes, which have low basal ROS
levels, a mitochondrial-derived ROS burst is required for TGFβ induced apoptosis whereas in
cirrhotic hepatocytes, which have an increased basal level of ROS, pretreatment with an
antioxidant permits a TGFβ-induced mitochondrial ROS response with subsequent apoptosis.
These studies further suggest that the mitochondria in cirrhotic hepatocytes are not irreversibly
damaged and that adequate energy stores are present to permit apoptosis. The mechanisms that
regulate these ROS-mediated responses are unknown and warrant further investigation.
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(A) Cirrhotic hepatocytes were pretreated with exogenous antioxidants including
deferoxamine (DEF; 1.5mM), glutathione (GLUT; 5 mM), DPPD (5 μM), or N-acetylcysteine
(NAC; 2.5 mM) for one hour prior to administration of TGFβ (5 ng/ml) and ROS activity
measured 90 minutes after TGFβ administration. The ROS activity, expressed as fold-
difference, returned to baseline at time zero (data not shown), but increased in response to
TGFβ treatment for all antioxidants tested. These findings suggest involvement of multiple
ROS generating pathways in increased cirrhotic hepatocyte basal ROS activity. (B) The percent
of condensed nuclei, indicative of morphologic apoptosis, was determined after cirrhotic
hepatocytes were pretreated with exogenous antioxidants (agents and dose identical to Fig. 1)
for one hour prior to treatment with or without TGFβ (5 ng/ml) and apoptosis determined at
48 hours. Pretreatment with the antioxidants alone did not induced apoptosis, but antioxidant
treatment followed by TGFβ administration increased markedly cirrhotic hepatocyte apoptosis
for each antioxidant tested.
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(A) Cirrhotic hepatocytes were transfected with adenoviruses (MOI 100) expressing luciferase
(AdLuc; control), catalase (AdCat), or MnSOD (AdMnSOD) for 24 hours and ROS activity
was fluorometrically determined using DCF. Some hepatocytes were untreated with
adenovirus (control). Transfection with AdCat and AdMnSOD decreased significantly ROS
formation (p<0.05 vs. control). (B) Cirrhotic hepatocytes were transfected with adenoviruses
(MOI 100) expressing luciferase (AdLuc), catalase (AdCat), or MnSOD (AdMnSOD) 24 hours
prior to TGFβ (5 ng/ml) treatment and incubated with DCF. Generation of ROS, expressed as
fold-difference, was fluorometrically determined at 90 minutes following TGFβ
administration. The adenoviruses expressing the antioxidants, catalase and MnSOD permitted
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a ROS burst at 90 minutes, indicating ROS responsiveness to TGFβ administration in cirrhotic
hepatocytes. (C) The percent of condensed nuclei, indicative of morphologic apoptosis, was
determined at 48 hours in cirrhotic hepatocytes in response to treatment with or without
TGFβ (5 ng/ml) after pretreatment for 24 hours with adenoviruses (100 MOI) expressing
luciferase (AdLuc), catalase (AdCat), or MnSOD (AdMnSOD). Transfection of cirrhotic
hepatocytes with adenoviruses expressing the antioxidants, catalase and MnSOD, followed by
treatment with TGFβ increased significantly the percent of apoptotic hepatocytes compared to
control (p<0.05 vs. control).
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Cleavage of caspase-3 by immunoblot was assessed at 48 hours to confirm apoptotic cell death
in cirrhotic hepatocytes transfected with adenoviruses (100 MOI) expressing luciferase
(AdLuc), catalase (AdCat), or MnSOD (AdMnSOD) for 24 hours prior to treatment with
TGFβ (5 ng/ml). (A) Cirrhotic hepatocytes were transfected with AdLuc alone (lane 1), AdLuc
followed by TGFβ (lane 2), AdMnSOD alone (lane 3), or AdMnSOD followed by TGFβ (lane
4). As expected, only infection with AdMnSOD followed by TGFβ treatment resulted in the
cleaved product indicating caspase-3 activity. (B) Cirrhotic hepatocytes were transfected with
AdLuc alone (lane 1), AdLuc followed by TGFβ (lane 2), AdCat alone (lane 3), or AdCat
followed by TGFβ (lane 4). The cleaved caspase-3 fragment was present only in AdCat infected
hepatocytes treated with TGFβ. (C) Caspase-3 activity, expressed as fold-difference, was
measured at 48 hours to confirm apoptotic cell death in cirrhotic hepatocytes transfected with
adenviruses (100 MOI) expressing luciferase, catalase, or MnSOD for 24 hours prior to
treatment with or without TGFβ (5 ng/ml). Infection with adenoviruses alone did not alter
caspase-3 activity whereas transduction of cirrhotic hepatocytes with antioxidant expressing
adenoviruses (AdCat and AdMnSOD) followed by TGFβ increased significantly caspase-3
activity. (D) The percent of condensed nuclei was determined 48 hours following TGFβ
treatment in cirrhotic hepatocytes infected with adenoviruses (MOI 100) expressing luciferase
(AdLuc), catalase (AdCat), or MnSOD (AdMnSOD) for 24 hours prior to TGFβ treatment (5
ng/ml). These hepatocytes were also pretreated with the pan-caspase inhibitor, zVAD (5 μM),
for one hour prior to treatment with or without TGFβ. Pretreatment with zVAD inhibited
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apoptosis in cirrhotic hepatocytes infected with AdCat and AdMnSOD confirming a caspase-
mediated form of cell death.
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Normal and cirrhotic hepatocytes were loaded with the fluorophores H2-DCFDA (2 μM; green)
to assess ROS formation and MitoTracker Red (MTR 500 nM; red) to localize respiring
mitochondria. Confocal microscopy was performed at 90 minutes following TGFβ (5 ng/ml)
administration. (A) Normal (left) and cirrhotic (right) hepatocytes were imaged without
treatment. Note a low mitochondrial ROS formation in normal hepatocytes while diffused ROS
formation in cirrhotic hepatocytes. (B) Normal hepatocytes were treated with TGFβ for 90
min. Some hepatocytes were transfected with AdMnSOD for 24 hours prior to TGFβ treatment.
Confocal imaging revealed a ROS burst in the mitochondria (yellow fluorescence, left panel),
which was suppressed by AdMnSOD transfection (middle and right panel). (C) Confocal
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imaging of cirrhotic hepatocytes. TGFβ alone did not caused a mitochondrial ROS burst (left
panel). Although AdMnSOD alone (middle panel) decreased ROS generation, subsequent
TGFβ administration induced a mitochondrial ROS burst (yellow, right panel). (D)
Quantification of yellow fluorescence, an indication of mitochondrial generation of ROS for
control and cirrhotic hepatocytes treated with TGFβ, AdMnSOD or TGFβ and AdMnSOD.
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(A) Whole tissue lysates were prepared from normal and cirrhotic livers and levels of Bcl-xL
and MCL-1 were determined by Western blot analysis. Actin levels were also immunoblotted
to ensure an equal protein loading. (B) Hepatocytes isolated from normal and cirrhotic livers
were incubated in HDM in the presence or absence of 5 ng/ml TGFβ, as described in
MATERIALS and METHODS. After 48 hours, cell lysates were prepared and total protein
tyrosine phosphatase activity was determined spectrometrically.
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(A) ROS fluorescent units (FU) were determined over time in normal, cirrhotic, and normal-
H2O2-converted hepatocytes. Normal hepatocytes (open circles) have a low basal level of ROS
activity whereas cirrhotic hepatocytes (black diamonds) have a high steady-state level of ROS
activity. Normal hepatocytes exposed to 10 μM H2O2 for 10 minutes (black triangles) failed
to maintain a sustained ROS response. However, normal hepatocytes exposed to 10 μM
H2O2 for 20 minutes (black squares) demonstrate sustained increased ROS activity similar to
basal cirrhotic hepatocytes over the study period. These hepatocytes had 97% viability (data
not shown). (B) The percent of condensed nuclei was determined in normal and H2O2-
converted hepatocytes at 48 hours after pretreatment (or not) with trolox (2 μM) followed by
treatment with or without TGFβ (5 ng/ml). Treatment with H2O2 alone did not increase
apoptosis, and, similar to cirrhotic hepatocytes, H2O2-converted cells were resistant to TGFβ
-induced apoptosis at 48 hours. However, H2O2-converted hepatocytes that were pretreated
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with trolox prior to TGFβ exposure underwent apoptosis similar to normal hepatocyte controls
and antioxidant-treated cirrhotic hepatocytes.
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Hepatocytes isolated from normal livers were incubated with 5 ng/ml TGFβ for 24 h. Some
hepatocytes were treated with 30 μM 2,3-dimethoxy-1,4-naphthoquinone (DMNQ) for 20 min
prior to TGFβ administration. After washing once, hepatocytes were further incubated with
TGFβ. Apoptosis was evaluated by chromatin condensation and nuclear fragmentation of PI-
stained nuclei (arrows), as described in MATERIALS and METHODS. TGFβ alone induced
a substantial apoptosis (A), which was reversed by a brief treatment with DMNQ (B).
Raval et al. Page 22
Free Radic Biol Med. Author manuscript; available in PMC 2007 December 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
